Berenberg Bank Reiterates Hiscox Ltd

Berenberg Bank reiterated a "Buy" recommendation for Hiscox Ltd - Depositary Receipt (OTCPK:HCXLY) on November 6, 2025, setting an average one-year price target of $41.95/share, which implies a 39.09% upside from its $30.16 closing price. This positive outlook is underpinned by strong financial projections, including a 37.85% increase in annual revenue to $5,413MM and a non-GAAP EPS of $1.62. Institutional ownership in HCXLY also saw a notable increase of 14.83% in total shares held over the last quarter, reaching 168K shares.

Analysis

Berenberg Bank has reiterated a 'Buy' recommendation for Hiscox Ltd - Depositary Receipt (OTCPK:HCXLY) on November 6, 2025, setting an average one-year price target of $41.95/share. This target implies a significant 39.09% upside from its latest reported closing price of $30.16/share, underpinned by strong financial projections including a 37.85% increase in annual revenue to $5,413MM and a non-GAAP EPS of $1.62. The analyst consensus ranges from $37.01 to $47.99, reinforcing a positive outlook.

Institutional ownership data reveals a net increase in positioning, with total shares owned by institutions rising by 14.83% to 168K shares over the last three months. While two specific funds, Great Lakes Advisors and CHICAGO TRUST Co NA, increased their shareholdings by 7.55% and 16.73% respectively, both firms simultaneously decreased their portfolio allocation in HCXLY by 54.93% and 16.81% over the last quarter, suggesting a rebalancing of overall portfolio weight despite increased absolute share count.

The overall sentiment surrounding HCXLY is strongly positive with a sentiment score of 0.75 and a bullish tone, reflecting confidence in the company's fundamentals and growth trajectory. This positive sentiment, combined with the substantial price target upside and projected revenue growth, positions HCXLY favorably in the near term. The increase in institutional share count, despite some allocation adjustments, indicates continued interest from sophisticated investors.

Key Decisions for Investors

• Investors should consider the strong analyst endorsement and the substantial implied upside of 39.09% to the $41.95 price target, supported by robust revenue and EPS projections.
• Close attention should be paid to future institutional filings, particularly the divergence between increased absolute share ownership and reduced portfolio weighting by some key holders, which may indicate rebalancing rather than conviction.
• Monitor upcoming earnings reports for confirmation of the projected 37.85% revenue growth and $1.62 non-GAAP EPS, as these are critical to sustaining the bullish outlook.